Actgen Pharma Private Limited, a active private limited company, was established on 08 March 2008 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239MH2008PTC179859. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹9.00 Cr.
It upholds a active non-compliant status. Its leadership includes Kantilal Mangalchand Hiran (Director), Dariyadevi Kantilal Hiran (Director). Past directors included Yogesh Uttamchand Hiran, Tirthraj Kabiraj Bangali, Ajay Dharamshi Virchand. It holds no open charges and ₹72.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 45, 1St Floor, Rustomjee Ease Zone, Goregaon Mulund Link Road, Malad (West),, Mumbai, Maharashtra, 400062.
U24239MH2008PTC179859
179859
08 March 2008
₹9.00 Cr
₹9.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Actgen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kantilal Mangalchand Hiran | Director | 05 Sep 2023 | Current |
| Dariyadevi Kantilal Hiran | Director | 06 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Nov 2023 | Past |
| Pramod Abcsdd | Additional Director | 20 Feb 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Actgen Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 980.2% increase. The company also saw a substantial improvement in profitability, with a 958.83% increase in profit. The company's net worth Soared by an impressive increase of 119.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Actgen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹720,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2010 | Bank Of India | ₹27.00 Cr | Satisfied |
| 27 Feb 2009 | Bank Of India | ₹27.00 Cr | Satisfied |
| 27 Nov 2008 | Bank Of India | ₹18.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Actgen Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Actgen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actgen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Actgen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Actgen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on Dariyadevi Kantilal Hiran was appointed as a Director was appointed as a Director on 06 Nov 2023 & has been associated with this company since 2 years 2 months . was documented.
Kantilal Mangalchand Hiran was appointed as a Director was appointed as a Director on 05 Sep 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
The activity A charge registered on 21 Jan 2010 via Charge ID 10199840 with Bank Of India was fully satisfied on 11 Apr 2019. was completed.
A charge registered on 27 Feb 2009 via Charge ID 10149092 with Bank Of India was fully satisfied on 11 Apr 2019. was recorded as a recent event.
The CIN of Actgen Pharma Private Limited is U24239MH2008PTC179859.
Actgen Pharma Private Limited is headquartered at Shop No. 45, 1St Floor, Rustomjee Ease Zone, Goregaon Mulund Link Road, Malad (West),, Mumbai, Maharashtra, 400062.
Actgen Pharma Private Limited was incorporated on 08 March 2008.
The current directors of Actgen Pharma Private Limited are
The primary industry of Actgen Pharma Private Limited is Manufacturing.
Actgen Pharma Private Limited is unlisted.
The authorized capital of Actgen Pharma Private Limited is ₹9.00 Cr, and the paid-up capital is ₹9.00 Cr.
The compliance status of Actgen Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX